| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Coastlands Capital LP | 5.98% | $20.7M | 4.76M | Matthew D. Perry | Nov 19, 2025 | |||
| VANGUARD GROUP INC | 5.54% | $10.3M | 3.32M | The Vanguard Group | Jun 30, 2025 | |||
| BlackRock, Inc. | 5.4% | $10.1M | 3.25M | BlackRock, Inc. | Jun 30, 2025 | |||
| ARMISTICE CAPITAL, LLC | 4.99% | $8.88M | 3.14M | Armistice Capital, LLC | Dec 31, 2024 | |||
| Frazier Life Sciences Public Fund, L.P. | 2% | $3.33M | 1.18M | James N. Topper | Dec 31, 2024 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 36.5M | $94.5M | -$12.2M | $2.59 | 82 |
| 2025 Q2 | 40.8M | $111M | +$5.56M | $2.71 | 85 |
| 2025 Q1 | 38.4M | $130M | -$2.28M | $3.39 | 83 |
| 2024 Q4 | 38.5M | $159M | +$82M | $4.12 | 75 |
| 2024 Q3 | 18.5M | $46M | +$411K | $2.49 | 33 |
| 2024 Q2 | 18.3M | $48.2M | +$22.9M | $2.64 | 31 |
| 2024 Q1 | 9.6M | $19.8M | +$915K | $2.06 | 28 |
| 2023 Q4 | 9.15M | $16.5M | +$507K | $1.80 | 28 |
| 2023 Q3 | 8.92M | $12.2M | -$169K | $1.37 | 28 |
| 2023 Q2 | 9.28M | $12.7M | +$2.93M | $1.37 | 32 |
| 2023 Q1 | 6.24M | $14.7M | -$15.1K | $2.36 | 29 |
| 2022 Q4 | 6.25M | $14.4M | -$296K | $2.28 | 26 |
| 2022 Q3 | 6.27M | $17.3M | -$726K | $2.76 | 26 |
| 2022 Q2 | 6.53M | $15.9M | -$1.24M | $2.44 | 28 |
| 2022 Q1 | 7M | $27.6M | -$4.35M | $3.94 | 31 |
| 2021 Q4 | 7.88M | $34.7M | -$3.53M | $4.41 | 35 |
| 2021 Q3 | 8.43M | $52.1M | -$6.53M | $6.18 | 32 |
| 2021 Q2 | 9.42M | $74.5M | +$5.45M | $7.91 | 30 |
| 2021 Q1 | 8.32M | $89M | +$88.6M | $10.70 | 32 |
| 2020 Q4 | 36.1K | $556K | +$556K | $15.40 | 1 |